G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	3.01B
Revenue (ttm)	273.77M
Net Income (ttm)	118.95M
Shares Out	59.00M
EPS (ttm)	2.02
PE Ratio	25.35
Forward PE	n/a
Dividend	0.76 (1.47%)
Ex-Dividend Date	n/a

Volume	14,316
Average Volume	18,520
Open	51.50
Previous Close	51.10
Day's Range	51.30 - 51.50
52-Week Range	45.00 - 61.70
Beta	-0.90
RSI	40.81
Earnings Date	Aug 7, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.